Morgan Stanley’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $347M | Buy |
5,156,282
+114,238
| +2% | +$7.61M | 0.02% | 732 |
|
|
2026
Q1 | $317M | Sell |
5,042,044
-30,602
| -0.6% | -$2.13M | 0.02% | 722 |
|
|
2025
Q4 | $337M | Buy |
5,072,646
+719,838
| +17% | +$46.5M | 0.02% | 680 |
|
|
2025
Q3 | $293M | Sell |
4,352,808
-1,249,747
| -22% | -$98.9M | 0.02% | 733 |
|
|
2025
Q2 | $489M | Sell |
5,602,555
-992,461
| -15% | -$77.8M | 0.03% | 505 |
|
|
2025
Q1 | $450M | Sell |
6,595,016
-313,376
| -5% | -$25.6M | 0.03% | 503 |
|
|
2024
Q4 | $537M | Buy |
6,908,392
+1,652,586
| +31% | +$122M | 0.04% | 450 |
|
|
2024
Q3 | $352M | Sell |
5,255,806
-375,140
| -7% | -$30.8M | 0.03% | 596 |
|
|
2024
Q2 | $638M | Buy |
5,630,946
+598,177
| +12% | +$75.6M | 0.05% | 352 |
|
|
2024
Q1 | $698M | Sell |
5,032,769
-69,031
| -1% | -$8.68M | 0.06% | 316 |
|
|
2023
Q4 | $633M | Buy |
5,101,800
+677,865
| +15% | +$69.3M | 0.06% | 311 |
|
|
2023
Q3 | $413M | Buy |
4,423,935
+245,364
| +6% | +$27.7M | 0.04% | 422 |
|
|
2023
Q2 | $537M | Buy |
4,178,571
+4,902
| +0.1% | +$593K | 0.05% | 345 |
|
|
2023
Q1 | $485M | Sell |
4,173,669
-146,841
| -3% | -$16.4M | 0.05% | 356 |
|
|
2022
Q4 | $489M | Sell |
4,320,510
-40,148
| -0.9% | -$4.41M | 0.06% | 345 |
|
|
2022
Q3 | $351M | Sell |
4,360,658
-29,191
| -0.7% | -$2.47M | 0.05% | 381 |
|
|
2022
Q2 | $327M | Buy |
4,389,849
+1,594,105
| +57% | +$145M | 0.04% | 416 |
|
|
2022
Q1 | $358M | Sell |
2,795,744
-621,980
| -18% | -$68M | 0.05% | 359 |
|
|
2021
Q4 | $459M | Sell |
3,417,724
-1,564,356
| -31% | -$225M | 0.06% | 307 |
|
|
2021
Q3 | $681M | Sell |
4,982,080
-3,613,392
| -42% | -$456M | 0.09% | 208 |
|
|
2021
Q2 | $918M | Sell |
8,595,472
-984,204
| -10% | -$94.5M | 0.12% | 172 |
|
|
2021
Q1 | $861M | Sell |
9,579,676
-2,856,228
| -23% | -$268M | 0.13% | 170 |
|
|
2020
Q4 | $1.15B | Sell |
12,435,904
-4,043,120
| -25% | -$361M | 0.18% | 135 |
|
|
2020
Q3 | $1.7B | Buy |
16,479,024
+1,900,912
| +13% | +$199M | 0.33% | 70 |
|
|
2020
Q2 | $1.48B | Sell |
14,578,112
-1,629,204
| -10% | -$146M | 0.33% | 73 |
|
|
2020
Q1 | $1.09B | Sell |
16,207,316
-490,668
| -3% | -$30.5M | 0.3% | 81 |
|
|
2019
Q4 | $913M | Buy |
16,697,984
+4,173,772
| +33% | +$198M | 0.21% | 108 |
|
|
2019
Q3 | $467M | Buy |
12,524,212
+268,016
| +2% | +$10.4M | 0.12% | 167 |
|
|
2019
Q2 | $459M | Sell |
12,256,196
-6,793,768
| -36% | -$214M | 0.12% | 163 |
|
|
2019
Q1 | $567M | Sell |
19,049,964
-1,816,016
| -9% | -$63.8M | 0.16% | 141 |
|
|
2018
Q4 | $625M | Sell |
20,865,980
-1,047,220
| -5% | -$33.2M | 0.19% | 119 |
|
|
2018
Q3 | $784M | Buy |
21,913,200
+1,797,704
| +9% | +$55.7M | 0.2% | 108 |
|
|
2018
Q2 | $478M | Buy |
20,115,496
+2,820,288
| +16% | +$59.8M | 0.13% | 160 |
|
|
2018
Q1 | $321M | Buy |
17,295,208
+1,388,648
| +9% | +$20.5M | 0.09% | 231 |
|
|
2017
Q4 | $228M | Buy |
15,906,560
+5,627,820
| +55% | +$73.2M | 0.06% | 311 |
|
|
2017
Q3 | $126M | Buy |
10,278,740
+424,420
| +4% | +$7.5M | 0.04% | 461 |
|
|
2017
Q2 | $180M | Buy |
9,854,320
+1,482,472
| +18% | +$27.4M | 0.05% | 361 |
|
|
2017
Q1 | $177M | Buy |
8,371,848
+1,278,524
| +18% | +$25M | 0.05% | 355 |
|
|
2016
Q4 | $106M | Buy |
7,093,324
+4,047,324
| +133% | +$71.7M | 0.03% | 514 |
|
|
2016
Q3 | $66.8M | Sell |
3,046,000
-330,916
| -10% | -$7.37M | 0.02% | 700 |
|
|
2016
Q2 | $67M | Sell |
3,376,916
-1,133,084
| -25% | -$19.3M | 0.02% | 657 |
|
|
2016
Q1 | $76.6M | Sell |
4,510,000
-565,968
| -11% | -$9.45M | 0.03% | 559 |
|
|
2015
Q4 | $104M | Buy |
5,075,968
+30,648
| +0.6% | +$638K | 0.04% | 472 |
|
|
2015
Q3 | $108M | Buy |
5,045,320
+4,253,472
| +537% | +$94.9M | 0.04% | 444 |
|
|
2015
Q2 | $15.8M | Buy |
791,848
+233,364
| +42% | +$4.1M | 0.01% | 1695 |
|
|
2015
Q1 | $8.7M | Buy |
558,484
+147,368
| +36% | +$2.23M | ﹤0.01% | 2207 |
|
|
2014
Q4 | $5.66M | Sell |
411,116
-204,272
| -33% | -$2.5M | ﹤0.01% | 2611 |
|
|
2014
Q3 | $6.15M | Buy |
615,388
+225,228
| +58% | +$2.3M | ﹤0.01% | 2455 |
|
|
2014
Q2 | $3.87M | Sell |
390,160
-55,740
| -13% | -$494K | ﹤0.01% | 2912 |
|
|
2014
Q1 | $4.61M | Buy |
445,900
+8,424
| +2% | +$87.1K | ﹤0.01% | 2652 |
|
|
2013
Q4 | $3.87M | Buy |
437,476
+117,964
| +37% | +$934K | ﹤0.01% | 2804 |
|
|
2013
Q3 | $2.25M | Buy |
319,512
+30,688
| +11% | +$194K | ﹤0.01% | 3122 |
|
|
2013
Q2 | $1.62M | Buy |
+288,824
| New | +$1.38M | ﹤0.01% | 3330 |
|
Other funds holding DXCM
Morgan Stanley's DXCM Position: Q2 2026 in Review
Morgan Stanley increased its DexCom (DXCM) stake by 2.3% in Q2 2026, buying an estimated $7.61M and bringing the position to 5,156,282 shares worth $347M. The position accounts for 0.02% of the portfolio, ranked #732.
Morgan Stanley first reported a position in DXCM in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.7B in Q3 2020. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Morgan Stanley held 5,156,282 shares of DexCom worth $347M as of Q2 2026.
- Morgan Stanley bought 114,238 DexCom shares in Q2 2026, an estimated $7.61M.
- DexCom made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #732 holding.
- Morgan Stanley first reported a position in DexCom in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's DexCom position peaked at $1.7B in Q3 2020.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.